ADMA Latest Headlines

ADMA Biologics Launches $125 Million Accelerated Share Buyback, Targeting $200 Million Repurchases in 2026

Market Chameleon (Mon, 2-Mar 7:35 AM)

ADMA Biologics announces $125M accelerated share repurchase with JPmorgan

at seekingalpha.com (Mon, 2-Mar 7:46 AM)

ADMA Biologics Launches Major 2026 Capital Return Plan

at www.tipranks.com (Mon, 2-Mar 7:45 AM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: RxSight (RXST), ADMA Biologics (ADMA) and Soleno Therapeutics (SLNO)

at www.tipranks.com (Thu, 26-Feb 10:31 AM)

ADMA forecasts $635M revenue for 2026 as ASCENIV drives margin expansion and new supply deals extend growth runway

at seekingalpha.com (Wed, 25-Feb 6:28 PM)

ADMA Biologics Announces CFO Transition and Leadership Change

at www.tipranks.com (Wed, 25-Feb 4:46 PM)

ADMA Biologics GAAP EPS of $0.20 beats by $0.02, revenue of $139.16M misses by $0.64M

at seekingalpha.com (Wed, 25-Feb 4:29 PM)

Here are the major earnings after the close Monday

at seekingalpha.com (Wed, 25-Feb 10:00 AM)

ADMA Biologics Sets Date to Unveil 2025 Financials—What Should Investors Watch for on February 25?

Market Chameleon (Wed, 18-Feb 9:43 AM)